Alzheimer, type 2 diabetes

Why thousands of dementia sufferers are being denied the new miracle drug
In late 2022, the results of a groundbreaking stage three trial for a ‘miracle’ new Alzheimer’s drug lecanemab were hailed as ...
NHS will not fund new drug to slow Alzheimer’s
A new drug that slows the pace of Alzheimer's disease is too expensive for too little benefit to be used on the NHS, the ...
New Alzheimer’s drug approved in UK, but government won’t pay for it
The drug is the second Alzheimer’s medicine to receive a lukewarm reception from the UK government in recent months.View on ...
New Alzheimer’s drug rejected for NHS use – because it’s not worth the money
New Alzheimer’s drug rejected for NHS use – because it’s not worth the money - Alzheimer’ patients in UK left behind over ...
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...
Alzheimer’s wonder drug faces NHS block over cost
The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare ...
UK regulator approves second Alzheimer’s drug in months but government won’t pay for it
Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after ...
STAT17h
Blood-based biomarkers for Alzheimer’s present complex challenges to health care system
The ability to possibly detect Alzheimer’s disease before symptoms emerge using blood-based biomarkers has introduced new ...
Ibj.com6d
UK regulator approves Lilly’s new Alzheimer’s drug but government won’t pay for it
Britian's National Institute for Health and Care Excellence said more evidence was needed to prove Kisunla's worth. Lilly ...
McKnight's Long-Term Care News6d
Study: Mailers don’t do much to lower high-risk med use in dementia patients
An educational mailer sent to doctors and people with Alzheimer’s disease or related dementias about reducing unneeded or ...